• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 23-27, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

May 23-27, 2011
FDA Official and TitleDateLocationOther FDA
Participants
Non-FDA
Participants
Subject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/24/11Washington, DCN/AN/ASpeech at the 2010-2011 Women’s Conservation Forum
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/25/11Boston, MAN/AN/APanel Remarks at One Mind for Research Forum on New Developments in Translational Science: Compounds to Cures
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/26/11New York, NYN/AN/ASpeech at the Hertog Global Strategy Initiative Lecture Series on Global Infectious Disease Threats and the Role of FDA: Past, Present and Future
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products5/26/11Washington, DCAnn SimoneauSeveral representatives from the American Heart Association,  the American Lung Association, and the American Cancer SocietyWebinar hosted by Campaign for Tobacco-Free Kids
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine5/26/11Rockville, MDWilliam Flynn, Dave White, Steve Vaughn, Pat McDermott)Mike Apley (Kansas State University College of Veterinary Medicine)Veterinary Medicine
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Acting Deputy Commissioner for Administration5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D.,  Director, Center for Biologics Evaluation and Research5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs5/23/11TeleconferenceJulie ZawiszaPeter Pitts (Center for Medicine in the Public Interest)Social Media Guidance for Industry
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/24/11Silver Spring, MDJonathan Sackner, Alberto Gutierrez, William Maisel, Rachel Turow, Barbara ZimmermanJill Olmstead, Chris Wasden, Albert Malvehy (Pricewaterhouse-
Coopers)
Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs5/23/11-5/27/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/22/11-5/24/11Sausalito, CARobert BeckerDonald Berry (The University of Texas MD Anderson Cancer Center); Laura Esserman (University of California San Francisco Medical Center); Anna Barker (Quantum Leap Foundation)Accelerating Targeted Cancer Drug-Biomarker Development through Innovative Pre-Competitive Collaborations and Clinical Trial Processes